Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Study in Healthy Children (<2 Years) to Evaluate the Safety and Efficacy of GSK Biologicals' Live Attenuated Varicella Vaccine (VarilrixTM) and of GSK Biologicals' Combined Measles-Mumps-Rubella-Varicella Vaccine
Varicella Vaccine
103494
NCT00226499
Varicella
Phase 3
 
This is a follow-up study to 100388. The results of this study 103494 are summarised with studies 100388, 104106, and 104105 on the GSK Clinical Study Register. An annotated case report form is not available for this study. A blank case report form will be provided.
January 2017

Powered by ideaPoint, Inc.